
35.54MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
KYG989MS1016
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.91
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.22
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
116,362,000
Gross Profit TTM
23,869,000
EBITDA
-44,623,000
Profit Margin
-59.97%
Return On Assets TTM
-9.48%
Return On Equity TTM
-25.17%
Revenue Per Share TTM
2.455
Qtly Revenue Growth YOY
-40.90%
Diluted Eps TTM
-0.22
Qtly Earnings Growth YOY
-79.60%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.2922
Price Book MRQ
0.9072
Enterprise Value Revenue
2
Enterprise Value EBITDA
21
155.71
4.31%9.23
2.90%33.80
1.78%43.42
1.12%30.89
1.08%13.60
0.00%85.45
0.00%30.19
0.00%221.75
-3.72%15.72
-0.51%